ZBTB48 is a pioneer factor regulating B-cell-specific CIITA expression

CIITA is the master regulator of MHC II gene expression and hence the adaptive immune response. CIITA expression itself is tightly regulated by three cell type- specific promoters, pI, pIII, and by pIV, and can also be induced by IFNψ in non- immune cells. While key regulatory elements have been identified within these promoters, knowledge of transcription factors regulating CIITA is incomplete. Here, we demonstrate that the telomere-binding protein and transcriptional activator ZBTB48 directly binds to both the critical activating elements within CIITA pIII and is essential for its gene expression. ZBTB48 establishes open chromatin at CIITA pIII upstream of activating H3K4me3 modifications both priming CIITA transcription for IFNψ-induction and ensuring constitutive expression in primary murine B cells. Hence, ZBTB48 acts as a molecular on-off-switch for B-cell-specific CIITA expression.

[1]  E. L. Denchi,et al.  TZAP overexpression induces telomere dysfunction and ALT-like activity in ATRX/DAXX-deficient cells. , 2023, iScience.

[2]  O. Dreesen,et al.  ZNF524 directly interacts with telomeric DNA and supports telomere integrity , 2022, bioRxiv.

[3]  B. Erman,et al.  Sibling rivalry among the ZBTB transcription factor family: homodimers versus heterodimers , 2022, Life Science Alliance.

[4]  A. Brazma,et al.  The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences , 2021, Nucleic Acids Res..

[5]  Thomas M. Keane,et al.  Twelve years of SAMtools and BCFtools , 2020, GigaScience.

[6]  Yunyu Shi,et al.  ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 , 2019, Nucleic acids research.

[7]  M. Schmitz,et al.  Formaldehyde-assisted Isolation of Regulatory Elements to Measure Chromatin Accessibility in Mammalian Cells , 2018, Journal of visualized experiments : JoVE.

[8]  Yunyu Shi,et al.  The 11th C2H2 zinc finger and an adjacent C-terminal arm are responsible for TZAP recognition of telomeric DNA , 2017, Cell Research.

[9]  F. Buchholz,et al.  ZBTB48 is both a vertebrate telomere‐binding protein and a transcriptional activator , 2017, EMBO reports.

[10]  E. Lazzerini Denchi,et al.  TZAP: A telomere-associated protein involved in telomere length control , 2017, Science.

[11]  M. Mann,et al.  Phylointeractomics reconstructs functional evolution of protein binding , 2017, Nature Communications.

[12]  Fidel Ramírez,et al.  deepTools2: a next generation web server for deep-sequencing data analysis , 2016, Nucleic Acids Res..

[13]  Doreen Ware,et al.  The iPlant Collaborative: Cyberinfrastructure for Enabling Data to Discovery for the Life Sciences , 2016, PLoS biology.

[14]  D. Higgs,et al.  Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX , 2015, Nature Communications.

[15]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[16]  G. Almouzni,et al.  Rapid induction of Alternative Lengthening of Telomeres by depletion of the histone chaperone ASF1 , 2013, Nature Structural &Molecular Biology.

[17]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[18]  Stephen H. Hughes,et al.  H3K4me3 Interactions with TAF3 Regulate Preinitiation Complex Assembly and Selective Gene Activation , 2013, Cell.

[19]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[20]  I. Ellis,et al.  Differential oestrogen receptor binding is associated with clinical outcome in breast cancer , 2011, Nature.

[21]  J. Carroll,et al.  Pioneer transcription factors: establishing competence for gene expression. , 2011, Genes & development.

[22]  Steven J. M. Jones,et al.  MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers , 2011, Nature.

[23]  A. Hamiche,et al.  The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3. , 2010, Genes & development.

[24]  R. Hannan,et al.  ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells. , 2010, Genome research.

[25]  M. Mann,et al.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.

[26]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[27]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[28]  W. Reith,et al.  Regulation of MHC class II gene expression by the class II transactivator , 2005, Nature Reviews Immunology.

[29]  Jan Hillert,et al.  MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction , 2005, Nature Genetics.

[30]  A. Wong,et al.  Regulation and Specificity of MHC2TA Promoter Usage in Human Primary T Lymphocytes and Cell Line1 , 2002, The Journal of Immunology.

[31]  C. Harding,et al.  Regulation of Class II MHC Expression in APCs: Roles of Types I, III, and IV Class II Transactivator1 , 2002, The Journal of Immunology.

[32]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[33]  W. Reith,et al.  Selective Abrogation of Major Histocompatibility Complex Class II Expression on Extrahematopoietic Cells in Mice Lacking Promoter IV of the Class II Transactivator Gene , 2001, The Journal of experimental medicine.

[34]  K. Wright,et al.  A Novel Element and a TEF-2-like Element Activate the Major Histocompatibility Complex Class II Transactivator in B-lymphocytes* , 1999, The Journal of Biological Chemistry.

[35]  R. Mantovani,et al.  The molecular biology of the CCAAT-binding factor NF-Y. , 1999, Gene.

[36]  J. M. Boss,et al.  CREB regulates MHC class II expression in a CIITA-dependent manner. , 1999, Immunity.

[37]  J. M. Boss,et al.  RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. , 1999, Immunity.

[38]  J. Ting,et al.  Two Distinct Gamma Interferon-Inducible Promoters of the Major Histocompatibility Complex Class II Transactivator Gene Are Differentially Regulated by STAT1, Interferon Regulatory Factor 1, and Transforming Growth Factor β , 1999, Molecular and Cellular Biology.

[39]  C. Benoist,et al.  Mice lacking the transcription factor CIITA--a second look. , 1998, International immunology.

[40]  R. Aebersold,et al.  A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients , 1998, Nature Genetics.

[41]  B. Crombrugghe,et al.  Role of the CCAAT-binding protein CBF/NF-Y in transcription. , 1998, Trends in biochemical sciences.

[42]  B. Mach,et al.  Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA , 1997, The EMBO journal.

[43]  P. Emery,et al.  RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency , 1997, The EMBO journal.

[44]  R. Flavell,et al.  Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. , 1996, Immunity.

[45]  B. Mach,et al.  Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome) , 1993, Cell.

[46]  W. Reith,et al.  Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X , 1988, Cell.

[47]  W. Fiers,et al.  Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon , 1983, Nature.

[48]  Andreas Ritter,et al.  Manipulating The Mouse Embryo A Laboratory Manual , 2016 .

[49]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[50]  C. Glass,et al.  Roles of lineage-determining transcription factors in establishing open chromatin: lessons from high-throughput studies. , 2012, Current topics in microbiology and immunology.

[51]  Ira M. Hall,et al.  BEDTools: a flexible suite of utilities for comparing genomic features , 2010, Bioinform..

[52]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[53]  Vincent B. Chen,et al.  Acta Crystallographica Section D Biological , 2001 .

[54]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[55]  B. Hogan,et al.  Manipulating the mouse embryo: A laboratory manual , 1986 .